Literature DB >> 20395349

The vascular biology of atherosclerosis and imaging targets.

Peter Libby1, Marcelo DiCarli, Ralph Weissleder.   

Abstract

The growing worldwide health challenge of atherosclerosis, together with advances in imaging technologies, have stimulated considerable interest in novel approaches to gauging this disease. The last several decades have witnessed a burgeoning in understanding of the molecular pathways involved in atherogenesis, lesion progression, and the mechanisms underlying the complications of human atherosclerotic plaques. The imaging of atherosclerosis is reaching beyond anatomy to encompass assessment of aspects of plaque biology related to the pathogenesis and complication of the disease. The harnessing of these biologic insights promises to provide a plethora of new targets for molecular imaging of atherosclerosis. The goals for the years to come must include translation of the experimental work to visualization of these appealing biologic targets in humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395349     DOI: 10.2967/jnumed.109.069633

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  52 in total

Review 1.  Isoforms of vitamin E differentially regulate inflammation.

Authors:  Joan M Cook-Mills; Christine A McCary
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-12       Impact factor: 2.895

2.  Fluorescence lifetime imaging for the characterization of the biochemical composition of atherosclerotic plaques.

Authors:  Jennifer Phipps; Yinghua Sun; Ramez Saroufeem; Nisa Hatami; Michael C Fishbein; Laura Marcu
Journal:  J Biomed Opt       Date:  2011-09       Impact factor: 3.170

3.  PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model.

Authors:  Xingyu Nie; Richard Laforest; Andrew Elvington; Gwendalyn J Randolph; Jie Zheng; Tom Voller; Dana R Abendschein; Suzanne E Lapi; Pamela K Woodard
Journal:  J Nucl Med       Date:  2016-07-07       Impact factor: 10.057

4.  Multimodality PET/MRI agents targeted to activated macrophages.

Authors:  Chuqiao Tu; Thomas S C Ng; Russell E Jacobs; Angelique Y Louie
Journal:  J Biol Inorg Chem       Date:  2013-10-29       Impact factor: 3.358

5.  Quantitative carotid PET/MR imaging: clinical evaluation of MR-Attenuation correction versus CT-Attenuation correction in (18)F-FDG PET/MR emission data and comparison to PET/CT.

Authors:  Jason Bini; Philip M Robson; Claudia Calcagno; Mootaz Eldib; Zahi A Fayad
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-02-15

6.  Design, construction, and validation of a rotary multifunctional intravascular diagnostic catheter combining multispectral fluorescence lifetime imaging and intravascular ultrasound.

Authors:  Julien Bec; Hongtao Xie; Diego R Yankelevich; Feifei Zhou; Yang Sun; Narugopal Ghata; Ralph Aldredge; Laura Marcu
Journal:  J Biomed Opt       Date:  2012-10       Impact factor: 3.170

7.  PET imaging of chemokine receptors in vascular injury-accelerated atherosclerosis.

Authors:  Yongjian Liu; Richard Pierce; Hannah P Luehmann; Terry L Sharp; Michael J Welch
Journal:  J Nucl Med       Date:  2013-05-08       Impact factor: 10.057

8.  Dexamethasone-induced insulin resistance: kinetic modeling using novel PET radiopharmaceutical 6-deoxy-6-[(18)F]fluoro-D-glucose.

Authors:  Kuan-Hao Su; Visvanathan Chandramouli; Faramarz Ismail-Beigi; Raymond F Muzic
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

Review 9.  Acute coronary syndromes: advances in antithrombotics.

Authors:  Nilusha Gukathasan; Roxana Mehran
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

Review 10.  Advances in nanotechnology for the management of coronary artery disease.

Authors:  June-Wha Rhee; Joseph C Wu
Journal:  Trends Cardiovasc Med       Date:  2012-12-13       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.